Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
Follow-Up Questions
IMMB hissesinin fiyat performansı nasıl?
IMMB 'in mevcut fiyatı $0.0001 'dir, son işlem günde 0% decreased etti.
Immunotech Laboratories Inc için ana iş temaları veya sektörler nelerdir?
Immunotech Laboratories Inc Biotechnology endüstrisine ait ve sektör Health Care 'dir
